Time course of the decline in renal function in cyclosporine-treated heart transplant recipients

American Journal of Nephrology

Volumn 14, Issue 1, 1994, Pages 1-5

  Zietse, Robert ^a   Balk, Aggie H ^a   Dorpel, Marinus A V D ^a   Meeter, Karin ^a   Bos, Egbert ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cyclosporine; Heart transplantation; Renal failure

Indexed keywords

CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CAUSE OF DEATH; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECIPIENT;

ADULT; CREATININE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGE; TIME FACTORS;

EID: 0028348863     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168677     Document Type: Article

References (15)

1. Macoviak JA, Oyer PE, Stinson EB, Jamieson SW, Baldwin JC, Shumway NE: Four years experience with cyclosporine for heart and heart-lung transplantation. Transplant Proc 1985;17:97-99.
2. Myers BD, Newton L: Cyclosporine-induced chronic nephropathy: An obliterative microvascular injury. J Am Soc Nephrol 1991;2:S45-S52.
3. Myers BD, Newton L, Boshkos C, Macoviak J, First WH, Derby GC, Perlroth MG, Sibley RK: Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988;46:694-703.
4. Tarantino A, Amoldi A, Stucchi L, Montagnino G, Mascaretti L, Vegeto A, Ponticelli C: A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation. Transplantation 1991;52:53-57.
5. Billingham ME: Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant 1981;1:1-6.
6. Billingham ME, Cary NAB, Hammond ME: A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990;9:987-991.
7. Jaffé M: Über den Niederschlag, welchen Pikrinsäure in normalem Ham erzeugt und über cine neue Reaction des Krcatinins. Physiol Chem 1886;10:391-403.
8. Greenberg A, Egel J, Thompson M, Bahnson H, Griffith B, Hardesty R, Puschett JB: Early and late forms of cyclosporine nephrotoxicity: Studies in cardiac transplant recipients. Am J Kidney Dis 1987;9:12-22.
9. Myers R, Ismail T, Angrisani J: Long-term renal function in liver transplantation. Transplant Proc 1991;23:1469-1471.
10. Zaltzman JS, York P, Maurer J, Patterson P, Cattran D: Cyclosporine nephrotoxicity in lung transplant recipients. Transplantation 1992;54:875-878.
11. Gonwa TA, Mai ML, Pilcher J, Johnson C, Pierson S, Capehart JE, Alivizatos PA: Stability of long-term renal function in heart transplantation patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant 1992;11:926-928.
12. Lewis RM, Van Buren CT, Radovancovic B: Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: Serial renal function in heart and kidney transplant recipients. J Heart Lung Transplant 1991;10:63-70.
13. Bertani T, Ferrazzi P, Schieppati A, Ruggenenti P, Gamba A, Parenzan L, Mecca G, Perico N, Imbcrti O, Remuzzi A, Remuzzi G: Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991;40:243-250.
14. Harper SJ, Moorhouse J, Veitch PS: Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients - A randomized prospective study. Transplantation 1992;54:742-743.
15. Versluis DJ, Wenting GJ, Derkx FHM, Jeekel J, Weimar W: Who should be converted from cyclosporine to conventional immunosuppression and why. Transplantation 1987;44:387-391.